Greene slams FDA green lighting of Moderna’s mNEXSPIKE COVID-19 vaccine
Rep. Marjorie Taylor Greene, a Republican from Georgia, has strongly criticized the recent decision by the U.S. Food and Drug Administration to approve Moderna’s mNEXSPIKE COVID-19 vaccine. In a post on social media platform X, Greene expressed her disapproval, stating, “Not MAHA at all!!!,” using the acronym for “Make America Healthy Again,” and calling the move “Unreal.”
The FDA’s approval of the mNEXSPIKE vaccine specifically allows its use in individuals who have previously been vaccinated with any COVID-19 vaccine and are either 65 years of age and older or 12 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19. This information was detailed in a letter from the FDA to Moderna.
Moderna, a company that specializes in mRNA medicine, stated in a press release that CEO Stéphane Bancel emphasized the ongoing threat of COVID-19, with over 47,000 Americans having died from the virus in the previous year alone.
Marjorie Taylor Greene has been vocal in her opposition to COVID-19 vaccines, advocating for the revocation of their FDA approval. In a tweet from March, she declared, “COVID-19 vaccines should have never received approval and they’ve known the entire time how bad the side effects are and deaths caused by them. It’s time to do the right thing. Stop the COVID-19 vaccines.”
Despite her controversial stance on vaccines, Greene is currently serving her third term in the House of Representatives. She has previously aired frustrations with the current state of affairs in politics, representing a dissatisfied Republican base.
In conclusion, Greene’s criticism of the FDA’s approval of the mNEXSPIKE vaccine reflects her ongoing skepticism towards COVID-19 vaccines. As the debate surrounding vaccine mandates and public health measures continues, her outspoken views contribute to the larger conversation on how best to address the pandemic.
